GlassScriptPhysician profile
Kashan Khan
NPI 1497959886
$3,665.87
in general payments reported to CMS, 2019-2025
35 companies · $533 in 2025
The $533 reported for 2025 was more than what 82% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $362 · 2021: $599 · 2022: $762 · 2023: $557 · 2024: $363 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $471.45 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $425.32 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $334.46 | 2021-2025 | |
| Glaxosmithkline, LLC. | $317.31 | 2020-2025 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $242.76 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $229.85 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $212.12 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $167.90 | 2021-2025 | Airsupra, Farxiga |
| Abbott Laboratories | $112.96 | 2022-2025 | Freestyle Libre |
| Amgen INC. | $109.07 | 2022-2025 | Otezla, Repatha, Otezla |
| Teva Pharmaceuticals USA, INC. | $108.61 | 2023 | Austedo Xr, Austedo, Uzedy |
| Merck Sharp & Dohme LLC | $108.42 | 2019-2023 | Verquvo, Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $94.71 | 2022-2023 | |
| Exact Sciences Corporation | $90.89 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $77.09 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $67.24 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $66.28 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.98 | 2019-2025 | Xifaxan |
| Dexcom, INC. | $39.65 | 2022-2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $30.31 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $26.32 | 2021-2022 | |
| Corcept Therapeutics | $23.85 | 2025 | Korlym |
| Shield Therapeutics INC | $23.65 | 2022 | |
| Xeris Pharmaceuticals, INC. | $22.96 | 2021 | |
| Nevro Corp. | $22.25 | 2024 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.17 | 2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $22.06 | 2021 | |
| Electromed, INC. | $20.47 | 2021 | |
| Horizon Therapeutics Plc | $18.55 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.20 | 2022 | |
| Phathom Pharmaceuticals, INC. | $17.02 | 2023 | Voquezna |
| Lundbeck LLC | $16.75 | 2023 | Rexulti |
| Antares Pharma, INC. | $16.58 | 2022 | |
| Abiomed | $15.44 | 2025 | |
| Eisai INC. | $13.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kashan Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.